1. Home
  2. NKTX vs OPRX Comparison

NKTX vs OPRX Comparison

Compare NKTX & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nkarta Inc.

NKTX

Nkarta Inc.

N/A

Current Price

$2.25

Market Cap

198.2M

Sector

Health Care

ML Signal

N/A

Logo OptimizeRx Corporation

OPRX

OptimizeRx Corporation

N/A

Current Price

$8.30

Market Cap

161.0M

ML Signal

N/A

Company Overview

Basic Information
Metric
NKTX
OPRX
Founded
2015
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
198.2M
161.0M
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
NKTX
OPRX
Price
$2.25
$8.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
6
Target Price
$10.83
★ $12.60
AVG Volume (30 Days)
★ 560.9K
155.2K
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
11.88
★ 124.55
EPS
N/A
★ N/A
Revenue
N/A
★ $109,429,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.77
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 18.78
52 Week Low
$1.70
$4.54
52 Week High
$3.72
$22.25

Technical Indicators

Market Signals
Indicator
NKTX
OPRX
Relative Strength Index (RSI) 31.83 56.48
Support Level $1.96 $6.92
Resistance Level $2.50 $9.08
Average True Range (ATR) 0.16 0.43
MACD -0.07 0.03
Stochastic Oscillator 12.35 54.76

Price Performance

Historical Comparison
NKTX
OPRX

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About OPRX OptimizeRx Corporation

OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.

Share on Social Networks: